Meeting Minutes for Approval:
September 10, 2020
Meeting Agenda:
December 10, 2020
Supplemental Old Business:
PD #8020-Respiratory Distress-Airway Managment (brought back to discuss Pediatric use of iGels)PD #8027-Symtomatic Nerve Agent Exposure Treatment (combined Policy 8027-Nerve Agent Exposure & 8826-Medication Administration, MARK 1 Nerve Agent Anntidote Kit)PD # 8062-Behavior Crisis: Restraint (brought back to discuss Ketamine use in combative patients and/or adding pediatrics)PD # 8830-Supraglottic Airway (iGel) (discussion of iGels for pediatrics)
Supplemental New Business:
PD# 2510- Designation Requirements for Ground Based Advanced Life Support (ALS) Service ProvidersPD #4400-Paramedic Accreditation (policy cleaned up)
Draft PD for Review:
PD #2521-Ambulance Offload Time (APOT) Data Collection and Reporting PD #2523-Administration of Naloxone for Law Enforcement/First Responders PD #4160-EMR Initial Certification and Recertification PD #4200-Mobile Intensive Care Nurse (MICN) Certification PD #4201-Mobile Intensive Care Nurse (MICN) RecertificationPD #4503-Public Safety/EMT AED Service Provider ApprovalPD #4504-Medical ControlPD #8060-StrokePD #8061-Decreased Sensorium PD #8810-Transcutaneous Cardiac Pacing (TCP)PD #8829-Noninvasive Ventilatory (NIV)PD #8831-Intranasal Medication AdministrationPD #9019-Brief Resolved Unexplained Event (BRUE)PD #9020-Pediatric Nausea and Vomiting
Public Comment Form